|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/127 | |
| C12N 15/11 |
| (11) | Patento numeris | 1648519 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04761574.5 |
| Europos patento paraiškos padavimo data | 2004-07-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-04-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2004/001051 |
| Data | 2004-07-16 |
| (87) | Numeris | WO 2005/007196 |
| Data | 2005-01-27 |
| (30) | Numeris | Data | Šalis |
| 488144 P | 2003-07-16 | US | |
| 503279 P | 2003-09-15 | US | |
| 529406 P | 2003-12-11 | US |
| (72) |
MACLACHLAN, Ian, CA
AMBEGIA, Ellen, Grace, CA
HEYES, James, CA
|
| (73) |
Protiva Biotherapeutics Inc.,
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8,
CA
|
| (54) | LIPID ENCAPSULATED INTERFERING RNA |
| LIPID ENCAPSULATED INTERFERING RNA |